Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Evaluating therapeutic benefits of ubrogepant via latent class models: A post hoc exploratory analysis of the ACHIEVE I and ACHIEVE II trials
Headache ( IF 5 ) Pub Date : 2023-10-24 , DOI: 10.1111/head.14631 Charlie J Iaconangelo 1 , Daniel Serrano 2 , Aubrey Manack Adams 3 , Joel M Trugman 4 , Richard B Lipton 5
Headache ( IF 5 ) Pub Date : 2023-10-24 , DOI: 10.1111/head.14631 Charlie J Iaconangelo 1 , Daniel Serrano 2 , Aubrey Manack Adams 3 , Joel M Trugman 4 , Richard B Lipton 5
Affiliation
To evaluate an alternative method of defining acute treatment success in migraine by combining multiple indicators into a single dichotomous measure of success.
中文翻译：
通过潜在类别模型评估 ubrogepant 的治疗效果：ACHIEVE I 和 ACHIEVE II 试验的事后探索性分析
通过将多个指标组合成单一的二分法成功衡量标准来评估定义偏头痛急性治疗成功的替代方法。
更新日期：2023-10-24
中文翻译：
通过潜在类别模型评估 ubrogepant 的治疗效果：ACHIEVE I 和 ACHIEVE II 试验的事后探索性分析
通过将多个指标组合成单一的二分法成功衡量标准来评估定义偏头痛急性治疗成功的替代方法。
京公网安备 11010802027423号